Skip to content

Rose K2 PG Optimum Extra Red

by Multilens AB Sweden EUDAMED

Ref N70253Model Corneal trial lenses, Optimum Extra EMDN Q02100402

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number731686cornealTrialOEMTSJZ Basic UDI-DIDate28 Sep 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/MDR Active

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 24 Oct 2026

Model / Reference
Corneal trial lenses, Optimum Extra, N70253
Primary DI / UDI-DI
731686N70253RN
Basic UDI-DI
731686cornealTrialOEMTSJZ
EMDN Code
Q02100402 Contact lenses - non hydrogel
Device Class
Class I
Special Device Type
Standard Rigid Gas Permeable (RGP) Contact Lenses
Market of Registration
Sweden

Manufacturer details

EUDAMED SRN
SE-MF-000002792

Other devices from Multilens AB

See all devices from Multilens AB →

Properties & raw data

Show properties, registry sources and raw records
Other properties (13)
  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED 7814216a-7c28-4153-9b92-3754c9bc940d 61 fields · synced 24 Oct 2026